Phillips James Michael
SVP, Research & Development at PACB
- Sold, on record
- $703k
- Dollars the filings state
- Form 4 sales
- 7
- Latest Mar 24, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- PACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC.SVP, Research & Development
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale PACBPlan not statedAug 7 2015
Sold 16,689 shares at $4.61 ($77k)
Phillips James Michael, SVP, Research & Development
Sold 8.5% of holdings ($903k position)179,160 shares leftFirst sale on recordFiling
- 2 Form 4 sale PACBPlan not statedApr 25 +262 days
Sold 20,000 shares at $10.29 ($206k)
Phillips James Michael, SVP, Research & Development
Sold 9.9% of holdings ($2.1M position)181,449 shares leftFiling
- 3 Form 4 sale PACBPlan not statedJul 29 +95 days
Sold 20,000 shares at $8.45 ($169k)
Phillips James Michael, SVP, Research & Development
Sold 9.9% of holdings ($1.7M position)181,449 shares leftFiling
- 4 Form 4 sale PACBPlan not statedOct 28 +91 days
Sold 20,000 shares at $8.44 ($169k)
Phillips James Michael, SVP, Research & Development
Sold 9.9% of holdings ($1.7M position)181,449 shares left1x usual sizeFiling
- 5 Form 4 sale PACBPlan not statedFeb 19 +844 days
Sold 7,231 shares at $7.17 ($52k)
Phillips James Michael, SVP, Research & Development
Sold 3.1% of holdings ($1.7M position)229,530 shares leftFirst sale on recordFiling
- 6 Form 4 sale PACBPlan not statedFeb 20 +366 days
Sold 5,050 shares at $4.48 ($23k)
Phillips James Michael, SVP, Research & Development
Sold 2% of holdings ($1.2M position)251,980 shares leftFiling
- 7 Form 4 sale PACBPlan not statedMar 24 +33 days
Sold 2,760 shares at $3.05 ($8k)
Phillips James Michael, SVP, Research & Development
Sold 1.1% of holdings ($769k position)249,220 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 24, 2020 | PACB | SVP, Research & Development | Form 4 sale | 2,760 | $8k | 1.1% | Plan not stated | SEC |
| Feb 20, 2020 | PACB | SVP, Research & Development | Form 4 sale | 5,050 | $23k | 2.0% | Plan not stated | SEC |
| Feb 19, 2019 | PACB | SVP, Research & Development | Form 4 sale | 7,231 | $52k | 3.1% | Plan not stated | SEC |
| Oct 28, 2016 | PACB | SVP, Research & Development | Form 4 sale | 20,000 | $169k | 9.9% | Plan not stated | SEC |
| Jul 29, 2016 | PACB | SVP, Research & Development | Form 4 sale | 20,000 | $169k | 9.9% | Plan not stated | SEC |
| Apr 25, 2016 | PACB | SVP, Research & Development | Form 4 sale | 20,000 | $206k | 9.9% | Plan not stated | SEC |
| Aug 7, 2015 | PACB | SVP, Research & Development | Form 4 sale | 16,689 | $77k | 8.5% | Plan not stated | SEC |